New to Meducation?
Sign up
Already signed up? Log In
view moderators

PublicHealth

Category

Preview
1
6

Rwandan life expectancy doubles in last 20 years, study finds

Country has seen dramatic progress since 1994 genocide that left it one of the world's poorest and sickest nations  
the Guardian
over 7 years ago
Logo medscape2013
1
23

Androgen Insensitivity Syndrome: Background, Pathophysiology, Epidemiology

Androgen insensitivity syndrome (AIS), formerly known as testicular feminization, is an X-linked recessive condition resulting in a failure of normal masculinization of the external genitalia in chromosomally male individuals. This failure of virilization can be either complete androgen insensitivity syndrome (CAIS) or partial androgen insens...  
emedicine.medscape.com
over 7 years ago
Preview
5
132

Circle of Willis Anatomy and Brain Aneurysms video - Animation and Narration by Cal Shipley, M.D.

http://www.calshipleymd.com Animated review of the anatomy and function of the Circle of Willis in the brain, the formation and rupture of saccular (berry) a...  
YouTube
over 7 years ago
Preview
0
9

Health atlas allows online search of risk by area - BBC News

A new online map of England and Wales allows people to enter their postcode and find their community's level of risk of developing 14 conditions, such as heart disease and lung cancer.  
BBC News
over 7 years ago
Preview
0
17

Wales NHS emergency care suffers uncertainty, AMs say - BBC News

Emergency care in Welsh hospitals suffers from uncertainty over the future of A&E units, an assembly committee says.  
BBC News
over 7 years ago
Www.bmj
1
17

Using haemoglobin A1c to diagnose type 2 diabetes or to identify people at high risk of diabetes

Haemoglobin A1c (HbA1c) can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease  
bmj.com
over 7 years ago
Www.bmj
1
9

Using haemoglobin A1c to diagnose type 2 diabetes or to identify people at high risk of diabetes

Haemoglobin A1c (HbA1c) can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease  
bmj.com
over 7 years ago
Www.bmj
1
2

The plight of the international medical graduate

It can’t feel great to be an international medical graduate in Britain right now. Ahead of next month’s European elections, candidates of all political hues are trying to neutralise the appeal of the tiny UK Independence Party by borrowing its anti-immigration rhetoric.  
www.bmj.com
over 7 years ago
Preview
0
11

How is the NHS performing? April 2014

Our eleventh Quarterly Monitoring Report features survey results from finance directors and interactive charts on selected NHS performance data.  
kingsfund.org.uk
over 7 years ago
Preview
0
13

How is the health and social care system performing? January 2014

While our analysis of key performance data in the latest quarterly monitoring report shows that NHS performance is holding up well, the survey findings from finance directors working in the health and social care sectors suggest that financial pressures are increasing. While our analysis of key performance data in the latest quarterly monitoring report shows that NHS performance is holding up well, the survey findings from finance directors working in the health and social care sectors suggest that financial pressures are increasing.  
kingsfund.org.uk
over 7 years ago
Www.bmj
1
19

FDA chief defends Zohydro approval as US states rebel

Margaret Hamburg, commissioner of the US Food and Drug Administration, has defended her agency’s decision to approve the potent long acting opioid Zohydro ER, arguing that the FDA had to balance the risks of opioid prescription abuse with “the very real medical needs of the estimated 100 million Americans living with severe chronic pain or coping with pain at the end of life, which is also a major public health problem in this country.”  
bmj.com
over 7 years ago
Www.bmj
1
3

TV advertisement that linked alcohol with cancer was not misleading, says UK regulator

The UK Advertising Standards Authority has rejected complaints by the drinks industry that a hard hitting public health commercial depicting a tumour growing in a glass of beer was misleading and irresponsible.  
bmj.com
over 7 years ago
Preview
2
32

Who, when and how: Screening for MRSA

Stream Who, when and how: Screening for MRSA by BMJ talk medicine from desktop or your mobile device  
SoundCloud
over 7 years ago
Preview
1
38

HPV vaccination and cervical cancer screening in Australia

Stream HPV vaccination and cervical cancer screening in Australia by BMJ talk medicine from desktop or your mobile device  
SoundCloud
over 7 years ago
Www.bmj
1
31

Drowning

Copyrighted Material, used by arrangement with John Wiley & Sons Limited. For personal use only, must not be reproduced or shared with third parties. Anyone wishing to reproduce this content in whole or in part, in print or in electronic format, should contact digitalrightsuk@wiley.com  
bmj.com
over 7 years ago
Www.bmj
1
32

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 7 years ago
Www.bmj
1
21

Non-response bias versus response bias

Researchers used a postal questionnaire survey to investigate the career progression of NHS doctors. The questionnaire included details about past and current employment, future career plans, and when career milestones were reached. Analysis was confined to respondents working in the UK NHS (including those with an honorary NHS contract). The participants were all those who graduated from UK medical schools in 1977, 1988, and 1993. The questionnaire was sent to 10 344 graduates, of whom 7012 replied, giving a response rate of 68%.1  
bmj.com
over 7 years ago
Www.bmj
1
23

Anticoagulation in atrial fibrillation

Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide. The use of oral anticoagulation in patients with atrial fibrillation at moderate or high risk of stroke, estimated by established criteria, improves outcomes. However, to ensure that the benefits exceed the risks of bleeding, appropriate patient selection is essential. Vitamin K antagonism has been the mainstay of treatment; however, newer drugs with novel mechanisms are also available. These novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) obviate many of warfarin’s shortcomings, and they have demonstrated safety and efficacy in large randomized trials of patients with non-valvular atrial fibrillation. However, the management of patients taking warfarin or novel agents remains a clinical challenge. There are several important considerations when selecting anticoagulant therapy for patients with atrial fibrillation. This review will discuss the rationale for anticoagulation in patients with atrial fibrillation; risk stratification for treatment; available agents; the appropriate implementation of these agents; and additional, specific clinical considerations for treatment.  
bmj.com
over 7 years ago
Www.bmj
2
22

A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims

Objective To compare the performance of two new approaches to risk adjustment that are free of the influence of observational intensity with methods that depend on diagnoses listed in administrative databases.  
bmj.com
over 7 years ago